Corpay, Inc. · CPAY · FY2025 Q2 · Calendar Q3 2025

Corpay Q2 2025: Growth Raised, Lodging Lags

The supplied analysis supports a constructive but qualified view: resilient demand in Corporate Payments, expanding payables products and cross-border partnerships, and raised guidance provide evidence for continued growth. That case is tempered by Lodging weakness, execution risk in M&A and divestitures, and exposure to tariff, FX and regulatory uncertainty.

Reported After market closeNYSETechnology $25.79B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $5.13 Consensus $5.12
EPS surprise +0.2% Reported versus consensus
Reported revenue $1.10B Consensus $1.10B
Revenue surprise +0.2% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -3.4% Event window
SPY move -0.1% Same window
Abnormal move -3.3% Stock minus SPY
Volume 2.8× Versus trailing sessions
Subsequent drift +4.0% Up to 20 sessions
CPAYSPY benchmark

Ask FN2 about CPAY FY2025 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior quarter, guidance moved from maintained to raised. The current analysis adds stronger evidence on Corporate Payments and Vehicle Payments growth, while identifying continued Lodging weakness and new execution priorities around Alpha, Circle, Corpay Complete, MCA and divestitures.

Guidance delta

Management raised full-year guidance modestly, an improvement from the prior quarter's maintained guidance.

Key takeaways

  • Q2 revenue and EPS beat expectations, with 13% year-over-year growth.
  • Corporate Payments delivered 18% organic growth, while Vehicle Payments was expected to reach 10% organic growth in the second half.
  • Lodging declined 2% year over year and remains a drag.
  • Management highlighted Alpha, Circle, Corpay Complete and MCA as growth initiatives, alongside planned non-core divestitures.

Management priorities

  • Close the Alpha acquisition in Q4 and integrate recent M&A.
  • Scale the Circle partnership for stablecoin on- and off-ramps.
  • Expand Corpay Complete internationally and pursue enterprise payables clients.
  • Execute non-core divestitures to fund growth and improve the portfolio.

Follow CPAY with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CPAY REVENUE earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $938M Q1 '24 actual $935M, miss Q2 '24 estimate $975M Q2 '24 actual $976M, match Q3 '24 estimate $1B Q3 '24 actual $1B, beat Q2 '25 estimate $1B Q2 '25 actual $1B, beat Q3 '25 estimate $1B Q3 '25 actual $1B, beat Q4 '25 estimate $1B Q4 '25 actual $1B, beat Q1 '26 estimate $1B Q1 '26 actual $1B, beat Q2 '26 estimate $1B Q2 '26 actual $1B, beat Q3 '26 estimate $1B Q4 '26 estimate $1B Q1 '27 estimate $1B
Show 1 more >

Analyst Consensus ?

ConsensusBuy18 ratings
Bullish1477.8%
Neutral422.2%
Bearish00.0%

Analyst 52W Price Targets

$401.93Current
$285Low
$405.57Average
$536High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 5, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
RBC Capital Sector Perform Sector PerformMaintainAug 31, 2026
Wolfe Research Outperform OutperformMaintainAug 25, 2026
Cantor Fitzgerald Overweight OverweightMaintainAug 10, 2026
UBS Neutral NeutralMaintainAug 6, 2026
Keefe, Bruyette & Woods Outperform OutperformMaintainAug 6, 2026
Show 13 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $401.92. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
ScotiabankAnalyst unavailable$536$404.81 +33.4%Sep 2, 2026
RBC CapitalAnalyst unavailable$438$407.88 +9.0%Aug 31, 2026
Wolfe ResearchAnalyst unavailable$530$413.92 +31.9%Aug 25, 2026
Cantor FitzgeraldRamsey El-Assal$480$397.2 +19.4%Aug 10, 2026
Morgan StanleyAnalyst unavailable$455$397.55 +13.2%Aug 7, 2026
See 35 more

Track every rating change on CPAY the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Corpay, Inc. operates as a global financial technology firm, delivering payment solutions that assist both businesses and individual consumers in efficiently managing a diverse range of expenditures. Its expertise primarily covers vehicle-related costs, corporate financial transactions, and lodging expenses, with operations spanning the United States, Brazil, the United Kingdom, and numerous other international markets. Among its specialized services are comprehensive vehicle payment offerings, which include provisions for fuel, road tolls, parking fees, fleet maintenance, and long-distance transportation. The company also supplies prepaid vouchers and cards for food and transit requirements.…

Historical context

All CPAY earnings

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CPAY recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-10-05T15:10:42.515289+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-05T15:10:42.512357+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-05. For educational purposes only; not investment advice.